CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-15 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +46,034 | $0.30 | $14K | 141,134 |
| 2022-07-15 | Lachey Jennifer Chief Scientific Officer | Sale | −46,034 | $30.00 | $1.4M | 95,100 |
| 2022-07-15 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −46,034 | 8,755 | ||
| 2022-07-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +1,916 | $0.30 | $575 | 93,184 |
| 2022-07-13 | Lachey Jennifer Chief Scientific Officer | Sale | −1,916 | $30.00 | $57K | 95,100 |
| 2022-07-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,916 | 54,789 | ||
| 2022-06-14 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +9,400 | $0.30 | $3K | 95,100 |
| 2022-06-14 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −9,400 | 56,705 | ||
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +5,300 | $0.30 | $2K | 91,000 |
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Sale | −3,398 | $41.26 | $140K | 87,602 |
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Sale | −944 | $42.49 | $40K | 86,658 |
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Sale | −719 | $43.32 | $31K | 85,939 |
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Sale | −223 | $44.23 | $10K | 85,716 |
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Sale | −16 | $45.45 | $727 | 85,700 |
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −5,300 | 66,105 | ||
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +5,300 | $0.30 | $2K | 91,000 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −1,417 | $61.37 | $87K | 89,583 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −1,009 | $62.32 | $63K | 88,574 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −2,315 | $63.50 | $147K | 86,259 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −559 | $64.15 | $36K | 85,700 |
Page 1 of 6 · 102 trades